Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib in HR-negative advanced breast cancer
NCT00559507Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2007
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saracatinib in breast cancer, sponsored by National Cancer Institute. Started Oct 2007; status: completed.
02
Drugs
saracatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00559507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559507.